Wordt geladen...
Natalizumab (Tysabri)
Natalizumab is a humanized IgG4κ monoclonal antibody that is a selective adhesion molecule inhibitor, which prevents adhesion of leukocytes to endothelial cells. It is the first monoclonal antibody approved by the FDA for the treatment of relapsing-remitting MS. This article will review the mechanis...
Bewaard in:
| Gepubliceerd in: | AJNR Am J Neuroradiol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Neuroradiology
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964985/ https://ncbi.nlm.nih.gov/pubmed/20688889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2226 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|